Abstract
Summary
In the present retrospective case-control study, we compared 6485 women with fractures and 6485 women without fractures from 135 general practitioner offices in the UK. Women without bone fractures were statistically more likely to have been exposed to oral contraception, depending on their age and therapy duration.
Introduction
The aim of this analysis was to compare the risk of bone fracture in women using hormonal contraception with that in women who have never used hormonal contraception.
Methods
A total of 6485 women (mean age 37.8 years) with an initial diagnosis of fracture between January 2010 and December 2015 were identified in 135 doctors’ offices in the UK Disease Analyzer database. In this nested case-control study, each case with a fracture was matched (1:1) to a control without a fracture for age, index year, and follow-up time. In total, 12,970 individuals were available for analysis. The main outcome of the study was the risk of fracture as a function of combined oral contraceptive (OC) therapy. Multivariate logistic regression models were used to determine the effect of OC therapy and its duration on the risk of fracture in the entire population and in four age-specific subgroups.
Results
Women without bone fractures were significantly more likely to have used oral contraception (OR 0.81). The usage of oral contraception was associated with a significantly lower risk of bone fracture (OR 0.81, 95% CI 0.74–0.90). This effect was strongest in the age groups 18–25 and 26–35 and in patients with an OC treatment duration of more than 1 year.
Conclusions
The present study revealed that women without bone fractures were significantly more likely to have had exposure to combined oral contraception, especially where the duration of intake was at least 5 years.
Similar content being viewed by others
References
The Family Planning Association (2007) Contraception: patterns of use factsheet. Accessed on 11/10/2016
Wiegratz I, Thaler CJ (2011) Hormonal contraception—what kind, when, and for whom? Dtsch Arzteblatt Int 108:495–505. doi:10.3238/arztebl.2011.0495quiz 506
Berlanda N, Somigliana E, Viganò P, Vercellini P (2016) Safety of medical treatments for endometriosis. Expert Opin Drug Saf 15:21–30. doi:10.1517/14740338.2016.1121991
Dinger J, Bardenheuer K, Heinemann K (2014) Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception 89:253–263. doi:10.1016/j.contraception.2014.01.023
Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM (2016) Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008815.pub4
Lopez L (2015) Hormonal birth control and fracture risk in observational studies. Cochrane Database. http://www.cochrane.org/CD009849/FERTILREG_hormonal-birth-control-and-fracture-risk-observational-studies
Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM (2012) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev. doi:10.1002/14651858.CD009849.pub2
Caserta D, Ralli E, Matteucci E, Bordi G, Mallozzi M, Moscarini M (2014) Combined oral contraceptives: health benefits beyond contraception. Panminerva Med 56:233–244
Dragoman MV (2014) The combined oral contraceptive pill—recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol 28:825–834. doi:10.1016/j.bpobgyn.2014.06.003
Trémollieres F (2013) Impact of oral contraceptive on bone metabolism. Best Pract Res Clin Endocrinol Metab 27:47–53. doi:10.1016/j.beem.2012.09.002
Kuohung W, Borgatta L, Stubblefield P (2000) Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 61:77–82
Herrmann M, Seibel MJ (2010) The effects of hormonal contraceptives on bone turnover markers. Clin Endocrinol 72:571–583
Vestergaard P, Rejnmark L, Mosekilde L (2006) Oral contraceptive use and risk of fractures. Contraception 73:571–576
Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626
Kyvernitakis I, Kostev K, Nassour T, Thomasius F, Hadji P (2016) The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. Osteoporos Int. doi:10.1007/s00198–016–3714-4
Pscherer S, Kostev K, Dippel FW, Rathmann W (2016) Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care. Diabetes Metab Syndr Obes Targets Ther 9:17–23. doi:10.2147/DMSO.S101370
Bohlken J, Jacob L, Schaum P, Rapp M, Kostev K (2015) Hip fracture risk in patients with dementia in German primary care practices. Dementia. doi:10.1177/1471301215621854
Schimdt N, Jacob L, Coleman R, Kostev K, Hadji P (2016) The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom. Breast Cancer Res Treat 155:151–157. doi:10.1007/s10549-015-3661-3
Michaëlsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S (1999) Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet Lond Engl 353:1481–1484. doi:10.1016/S0140-6736(98)09044-8
Fitzpatrick LA (2006) Estrogen therapy for postmenopausal osteoporosis. Arq Bras Endocrinol Metabol 50:705–719
Corson SL (1993) Oral contraceptives for the prevention of osteoporosis. J Reprod Med 38:1015–1020
Nappi C, Bifulco G, Tommaselli GA, Gargano V, Di Carlo C (2012) Hormonal contraception and bone metabolism: a systematic review. Contraception 86:606–621. doi:10.1016/j.contraception.2012.04.009
Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB (2005) Prior oral contraception and postmenopausal fracture: a Women’s Health Initiative observational cohort study. Fertil Steril 84(2):374–383
Isley MM, Kaunitz AM (2011) Update on hormonal contraception and bone density. Rev Endocr Metab Disord 12:93–106. doi:10.1007/s11154-011-9180-6
Cauley JA (2015) Estrogen and bone health in men and women. Steroids 99:11–15. doi:10.1016/j.steroids.2014.12.010
Marley WD, Kelly G, Thompson NW (2015) Alcohol-related fracture admissions: a retrospective observational study. Ulster Med J 84:94–97
Duckers JM, Evans BAJ, Fraser WD, Stone MD, Bolton CE, Shale DJ (2011) Low bone mineral density in men with chronic obstructive pulmonary disease. Respir Res 12:101. doi:10.1186/1465-9921-12-101
Jagielska GW, Przedlacki J, Bartoszewicz Z, Racicka E (2016) Bone mineralization disorders as a complication of anorexia nervosa—etiology, prevalence, course and treatment. Psychiatr Pol 50:509–520. doi:10.12740/PP/59289
Thornton D, Gordon CM (2016) Restrictive eating disorders and skeletal health in adolescent girls and young women. Calcif Tissue Int. doi:10.1007/s00223-016-0164-0
Fan H-C, Lee H-S, Chang K-P, Lee Y-Y, Lai H-C, Hung P-L, Lee H-F, Chi C-S (2016) The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci 17:1242. doi:10.3390/ijms17081242
Lin C-M, Fan H-C, Chao T-Y, Chu D-M, Lai C-C, Wang C-C, Chen S-J (2016) Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children—a medical center experience. BMC Pediatr 16:61. doi:10.1186/s12887-016-0597-7
Petty SJ, Wilding HW, Wark JD (2016) Osteoporosis associated with epilepsy and the use of anti-epileptics—a review. Curr Osteoporos Rep 14:54–65. doi:10.1007/s11914-016-0302-7
Rathmann W, Kostev K (2015 Aug) Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care. J Diabetes Complicat 29(6):766–770. doi:10.1016/j.jdiacomp.2015.05.007
Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D (2015 Feb) Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. Osteoporos Int 26(2):827–833. doi:10.1007/s00198-014-2986-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Dombrowski, S., Jacob, L., Hadji, P. et al. Oral contraceptive use and fracture risk—a retrospective study of 12,970 women in the UK. Osteoporos Int 28, 2349–2355 (2017). https://doi.org/10.1007/s00198-017-4036-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-017-4036-x